Community Health Systems, Inc. (CYH)
NYSE: CYH · IEX Real-Time Price · USD
3.335
+0.045 (1.37%)
Apr 30, 2024, 3:29 PM EDT - Market open

Community Health Systems Revenue

Community Health Systems had revenue of $12.52B in the twelve months ending March 31, 2024, with 2.57% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $3.14B with 1.03% year-over-year growth. In the year 2023, Community Health Systems had annual revenue of $12.49B with 2.28% growth.

Revenue (ttm)
$12.52B
Revenue Growth
+2.57%
P/S Ratio
0.04
Revenue / Employee
$260,896
Employees
48,000
Market Cap
455.88M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202312.49B279.00M2.28%
Dec 31, 202212.21B-157.00M-1.27%
Dec 31, 202112.37B579.00M4.91%
Dec 31, 202011.79B-1.42B-10.76%
Dec 31, 201913.21B-945.00M-6.68%
Dec 31, 201814.16B-1.20B-7.80%
Dec 31, 201715.35B-3.09B-16.73%
Dec 31, 201618.44B-999.00M-5.14%
Dec 31, 201519.44B798.00M4.28%
Dec 31, 201418.64B5.82B45.40%
Dec 31, 201312.82B-14.00M-0.11%
Dec 31, 201212.83B926.79M7.78%
Dec 31, 201111.91B813.79M7.34%
Dec 31, 201011.09B-650.03M-5.54%
Dec 31, 200911.74B823.36M7.54%
Dec 31, 200810.92B3.82B53.88%
Dec 31, 20077.10B2.92B69.75%
Dec 31, 20064.18B604.02M16.89%
Dec 31, 20053.58B372.61M11.63%
Dec 31, 20043.20B526.99M19.69%
Dec 31, 20032.68B513.14M23.72%
Dec 31, 20022.16B469.76M27.74%
Dec 31, 20011.69B356.12M26.63%
Dec 31, 20001.34B257.55M23.85%
Dec 31, 19991.08B225.37M26.37%
Dec 31, 1998854.58M112.23M15.12%
Dec 31, 1997742.35M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
LifeMD 152.55M
Avid Bioservices 136.74M
UroGen Pharma 82.71M
Taysha Gene Therapies 15.45M
Verve Therapeutics 11.76M
Fulcrum Therapeutics 2.81M
Oculis Holding AG 1.05M
Revenue Rankings